Dr. Shaun Xiaoliu Zhang, chair of the Department of Biology and Biochemistry at the 91视频鈥檚 College of Natural Sciences (NSM), has been appointed Associate Editor of Molecular Therapy Oncology.
The appointment marks a significant professional milestone, as Dr. Zhang joins the editorial board of this prestigious international publication. Molecular Therapy Oncology is an official journal of the American Society of Gene and Cell Therapy (ASGCT), a global organization representing more than 6,000 members across 60 countries. For Dr. Zhang, the role is both a testament to his expertise and an opportunity to contribute to the advancement of cancer research.
鈥淚 feel proud to represent NSM and the 91视频,鈥� said Zhang. 鈥淚t is an honor to take on this role because the journal serves the scientific community so well and is highly respected in the field of molecular therapy.鈥�
A Leader in Cancer Innovation
Dr. Zhang鈥檚 appointment to the journal鈥檚 editorial leadership follows his extensive research efforts focused on developing treatments for solid tumors. His work centers on oncolytic virotherapy, a cutting-edge approach that re-engineers benign viruses, such as the herpes simplex virus (HSV), to selectively target and kill malignant cells while leaving healthy tissue unharmed.
His lab鈥檚 unique platform goes beyond directly attacking tumors. It acts as a 鈥減rimer鈥� for the body鈥檚 immune system. By arming viruses with novel molecules, Dr. Zhang aims to overcome the limitations of current immunotherapies and expand treatment options for the majority of cancer patients who do not respond to existing therapies.
Global Impact from Houston
As Associate Editor, Dr. Zhang will help shape the direction of international research in gene and cell therapy. His dual background, holding an M.D. from Tongji Medical College and a Ph.D. from the Australian National University, provides clinical and research expertise to evaluate the next generation of potential cancer breakthroughs.
鈥淭his journal specifically focuses on oncology and molecular therapies, covering everything from immunotherapy to viral therapy,鈥� said Zhang. 鈥淚 am glad to have the opportunity to serve the community and represent our university on this international stage.鈥�
Dr. Zhang鈥檚 leadership reflects NSM鈥檚 growing influence in cancer research and its commitment to high-impact scientific discovery.